A detailed history of Kentucky Retirement Systems Insurance Trust Fund transactions in Moderna, Inc. stock. As of the latest transaction made, Kentucky Retirement Systems Insurance Trust Fund holds 10,015 shares of MRNA stock, worth $404,906. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,015
Previous 10,754 6.87%
Holding current value
$404,906
Previous $1.28 Million 47.61%
% of portfolio
0.05%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$63.64 - $125.14 $47,029 - $92,478
-739 Reduced 6.87%
10,015 $669,000
Q2 2024

Aug 12, 2024

SELL
$101.21 - $166.61 $19,533 - $32,155
-193 Reduced 1.76%
10,754 $1.28 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $74,357 - $100,548
-871 Reduced 7.37%
10,947 $1.17 Million
Q4 2023

Feb 08, 2024

BUY
$69.51 - $104.43 $24,189 - $36,341
348 Added 3.03%
11,818 $1.18 Million
Q3 2023

Oct 12, 2023

SELL
$96.41 - $126.61 $28,826 - $37,856
-299 Reduced 2.54%
11,470 $1.18 Million
Q2 2023

Aug 07, 2023

BUY
$118.5 - $160.53 $1,540 - $2,086
13 Added 0.11%
11,769 $1.43 Million
Q1 2023

May 10, 2023

SELL
$135.66 - $197.02 $40,833 - $59,303
-301 Reduced 2.5%
11,756 $1.81 Million
Q3 2022

Nov 16, 2022

BUY
$118.07 - $194.18 $27,628 - $45,438
234 Added 1.98%
12,057 $1.43 Million
Q2 2022

Aug 08, 2022

BUY
$117.13 - $176.59 $165,270 - $249,168
1,411 Added 13.55%
11,823 $1.69 Million
Q1 2022

May 09, 2022

BUY
$126.46 - $235.05 $137,714 - $255,969
1,089 Added 11.68%
10,412 $1.79 Million
Q4 2021

Feb 04, 2022

SELL
$225.82 - $368.51 $4,064 - $6,633
-18 Reduced 0.19%
9,323 $2.37 Million
Q3 2021

Nov 17, 2021

BUY
$221.9 - $484.47 $2.07 Million - $4.53 Million
9,341 New
9,341 $3.6 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kentucky Retirement Systems Insurance Trust Fund Portfolio

Follow Kentucky Retirement Systems Insurance Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems Insurance Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems Insurance Trust Fund with notifications on news.